跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ASPAVELI 1080 MG SOLUCION PARA PERFUSION - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
ASPAVELI 1080 MG SOLUCION PARA PERFUSION
Approved
STANDARD
ASPAVELI 1080 MG SOLUCION PARA PERFUSION
Swedish Orphan Biovitrum Ab (Publ)
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Dec 30, 2021
Approval ID
24e8dab9d6788689
Company
Swedish Orphan Biovitrum Ab (Publ)
Type
Standard
Approval Details
Approval Id
24e8dab9d6788689
Drug Cima Aemps Name
ASPAVELI 1080 MG SOLUCION PARA PERFUSION
Register Number
1211595001
Holder Company Name
Swedish Orphan Biovitrum Ab (Publ)
Marketing Company Name
Swedish Orphan Biovitrum S.L.
Holder Company Detail Path
/organization/swedish-orphan-biovitrum-ab-publ
Authorization Date
2021-12-30
Dosage Form
SOLUCIÓN PARA PERFUSIÓN
Dose
1080 mg
Route Of Administration
VÍA SUBCUTÁNEA
Prescription Type
Diagnóstico Hospitalario
Commercialized
Yes
Company Name
Swedish Orphan Biovitrum Ab (Publ)
Company Detail Path
/organization/swedish-orphan-biovitrum-ab-publ
Company Information
Pharmaceutical Company Name
Swedish Orphan Biovitrum AB (publ)
Name En
Swedish Orphan Biovitrum AB (publ)
Country Name
Sweden
City Name
solna,stockholm,country_se
Address
Tomtebodavägen 23A
Website
https://www.sobi.com
Active Ingredients
PEGCETACOPLAN
54 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Dec 30, 2021
Approval ID
24e8dab9d6788689
Type
Standard
Back to CIMA-AEMPS Approvals